Wallace H. Coulter Center for Translational Research

New episode of Biomedical Frontiers is out! Learn from David C. and Lisa Bowers about the challenges of translating biotech research into real-world solutions. ? Why healthcare #innovation is uniquely complex ? How biotech startups navigate funding, regulations, and clinical trials ? The role of interdisciplinary collaboration in driving medical breakthroughs ? Key trends shaping the #biomedical research and tech transfer ?? Listen now: https://lnkd.in/ew4RQz5Y ?? Resources Mentioned: CvilleBioHub The Manning Institute Alliance for Building Better Medicine and UVA’s Enterprise Studio #medtech #pharmatech #biotech #medicalinnovation #clinicaltrials

Our esteemed Seed Fund Manager Robert Creeden explains the #LVG process perfectly during an AUTM panel discussion this morning. #GreatAndGood #TechTransfer Richard Chylla PhD,CLP,RTTP Josh Mauldin Cortney Mushill (Armstrong) Johnathon Dooley

ASU President Michael Crow on the need for universities to make the case the innovation relies on universities: “Everyone thinks this iPhone 16 was the product of the genius — and he was a genius — of Steve Jobs. Hardly. There were probably, by my estimation, 5,000 academic research groups through the decades that had something to do with the technology I’m holding in my hand. Nobody even knows they exist. Nobody knows the hundreds of patents in here and the thousands of articles that back up the patents that are in here. I’m not just talking about the chips, the billions of transistors that are on a single chip, but the gorilla-glass that’s on the cover here and the surface ‘this’ and electronic ‘this.’” Crow further elaborated that the iPhone was “deeply enabled” by academic research activity — but the general public doesn’t know that. There are talented executives who are “genius” at integration, but the actual technology is based on the tens of thousands of discoveries that happen at research universities, he said. https://lnkd.in/gi2sGBus ASU Biodesign Institute Arizona State University Rice University

It’s been years in the making, and yesterday, we finally got to celebrate the grand opening of the Commonwealth BioAccelerator! ?? This will be an incredible resource for GO Virginia Region 9 and the entire Commonwealth, fueling innovation and opportunity for early-stage biotech companies. Huge congratulations to Nikki Hastings and the entire team at CvilleBioHub for making this vision a reality. I can’t wait to meet the first cohort and see the impact they’ll make! #BioAccelerator #ResearchRhombus #RememberTheWhy #projectvital Virginia Bio Verge (Roanoke Blacksburg Innovation Alliance) Activation Capital VIPC | Virginia Innovation Partnership Corporation GO Virginia

Thanks to everyone who came out to celebrate University of Virginia Innovators of the Year Silvia Blemker, Craig Meyer and Joe Hart! #GreatAndGood #TechTransfer #UVALVG Joe H. Richard Chylla PhD,CLP,RTTP Lori L. McMahon Philip Bourne Jennifer West Elizabeth Boucher Jill Simandl

Of the FDA employees fired last weekend, 2-3 hundred worked at the Center for Devices and Radiological Health, the agency division governing medical technology. Most of these people were responsible for reviewing new technologies, and these cuts will mean increased review times and delays in getting life-altering solutions to sick patients. Ironically, many of these positions were not funded by taxpayers but by the med tech companies themselves, who pay substantial application fees in exchange for the FDA's commitment to meet certain performance objectives (e.g., response times, inspection timeliness, etc.). If the goal here was to save taxpayer dollars and increase government efficiency, this won't do it! To those public servants who were impacted, please reach out to me here or through Integra LifeSciences at [email protected] - we'd love to see if we can help as you consider new opportunities. #integrainspired #medtech

Current and former UVA professors developed technology professional sports teams are using. https://lnkd.in/eUHyU_CZ

Great times, great people, and even better memories! ?? Had a blast connecting with Coulter Center friends and UVA BME Department alumni at our recent meet-up. Here’s to lifelong connections and the incredible impact our community continues to make! ????

Congratulations to Alexander Clark in Jeff Saucerman's Lab on receipt of both the American Heart Association Postdoctoral Fellowship and Wallace H. Coulter Center for Translational Research scholars award!

As a biomedical researcher and entrepreneur with over 30 years of NIH grant funding experience, I feel compelled to address the potential implications of Robert F. Kennedy Jr.'s proposed approach to conflicts of interest in scientific research. While integrity in science is paramount, we must carefully consider the unintended consequences of overly restrictive policies on America's biomedical innovation ecosystem. Here's why: 1. The Bayh-Dole Act has been transformative, generating $1.7 trillion in economic impact and numerous life-saving medical breakthroughs over 40 years.?This success relies on a delicate balance between innovation and oversight. 2. Researchers have an ethical obligation to engage in technology transfer, ensuring taxpayer-funded discoveries benefit public health. This process often necessitates navigating financial conflicts, e.g., patents, licenses, and/or startups resulting from research. 3. As global competition intensifies, particularly from China's advancing biotechnology sector, maintaining U.S. leadership is crucial. Overly restrictive policies could hamper our ability to compete effectively. 4. Counterintuitively, properly managed conflicts arising from technology transfer may enhance scientific rigor and accountability, as researchers face increased scrutiny from investors and legal consequences for misrepresentation. This aspect of Mr. Kennedy's pending leadership at HHS has received little attention during his senate confirmation hearing but could have far-reaching impacts on U.S. medicine, science, and its economy. As we navigate this critical juncture, it's essential to strike a balance that maintains scientific integrity without sacrificing the dynamism of our innovation ecosystem. What are your thoughts on balancing conflict management with the necessity of ensuring tech transfer of taxpayer-funded research? If my concern resonates with you, please consider: 1. Sharing this post to raise awareness. 2. Writing to your Senator and Representative to express your concern for U.S. science leadership and economic competitiveness. #BiomedicalInnovation #SciencePolicy #TechnologyTransfer #BayhDoleAct#BiomedicalResearch #Innovation #EconomicGrowth #SciencePolicy